FOXP3 and neoplasm: Currently, except for its inhibitive effect on topoisomerase, EPI is also an antagonist of Forkhead box protein p3 (Foxp3), which may hold the potential to regulate the immune microenvironment in tumor tissues and thus trigger the immunogenic cell death in tumor tissues.